Rhein

Rhein
Name	Rhein
IUPAC name	4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid
Other names	chrysophanic acid-9-carboxylic acid
CAS number	478-43-3
Formula	C15H8O6
Molar mass	284.22 g·mol−1
Appearance	yellow crystalline powder
Melting point	320–322 °C (decomp.)
Solubility	sparingly soluble in water; soluble in organic solvents

Rhein is an anthraquinone derivative found in several medicinal plants historically used in phytotherapy and traditional medicine traditions. It is chemically characterized as an oxidized tricyclic quinone with hydrophilic carboxyl and hydroxyl substituents that influence its reactivity, chromophore properties, and bioactivity. Rhein has been the subject of pharmacological, toxicological, biochemical and industrial analyses across phytochemistry, natural product chemistry, and medicinal chemistry research communities.

Chemistry and physical properties

Rhein is an anthraquinone carboxylic acid structurally related to anthraquinone pigments such as alizarin and chrysophanol, and shares its tetracyclic aromatic core with compounds studied in organic chemistry and chemical synthesis. The molecule presents conjugated carbonyl groups at C-9 and C-10 and phenolic hydroxyls at C-4 and C-5, producing an extended chromophore responsible for yellow coloration used in dye chemistry and spectrophotometry assays. Rhein's carboxylate provides modest acidity (pKa values in organic media), enabling salt formation and derivatization for increased aqueous solubility exploited in medicinal chemistry and pharmaceutical formulation development. Its solid-state behavior (high melting point, decomposition on heating) and limited water solubility have guided solvent selection for chromatography and X-ray crystallography studies.

Natural sources and biosynthesis

Rhein occurs in several plant taxa within families notable for anthraquinone production, including species of Rheum (rhubarb), Cassia (senna), and Aloe. It has also been detected in bark and roots of species used in traditional Chinese medicine and Ayurveda, where extracts serve as laxatives and topical agents. Biosynthetically, rhein is derived from the polyketide pathway involving acetyl-CoA and malonyl-CoA condensations to form anthrone intermediates, followed by oxidative cyclization and ring modification steps catalyzed by enzymes analogous to polyketide synthases characterized in fungal and plant secondary metabolism. Distribution within plant organs varies: roots and rhizomes often concentrate rhein and related anthraquinone glycosides such as rhein-8-glucoside; metabolomic surveys using LC–MS and NMR spectroscopy map these patterns across developmental stages and extraction methods.

Biological activities and pharmacology

Rhein exhibits multiple bioactivities documented in in vitro and in vivo models, including anti-inflammatory effects mediated by inhibition of enzymes and signaling pathways such as cyclooxygenase isoforms, nuclear factor kappa B, and mitogen-activated protein kinases studied in cell lines derived from human tissues. Reported antimicrobial activity spans Gram-positive and Gram-negative bacteria as well as Candida species, often assessed alongside other anthraquinones in microbiology assays. Rhein modulates apoptosis and cell-cycle regulatory proteins in cancer cell models of organs such as hepatic and colorectal origin, leading to investigations in oncology-related preclinical research. Additionally, rhein influences connective tissue metabolism by affecting matrix metalloproteinases and collagen turnover, which has implications in studies of osteoarthritis and fibrosis.

Medical and clinical research

Clinical interest in rhein has focused on its parent plant extracts and semisynthetic derivatives evaluated in trials related to osteoarthritis symptomatic relief and renal protection in diabetic nephropathy animal studies. Controlled clinical trials involving rhein-containing formulations (often compared with nonsteroidal anti-inflammatory agents such as ibuprofen or diclofenac) have reported mixed outcomes on pain scores and functional endpoints, prompting meta-analyses in evidence-based medicine literature. Pharmacokinetic investigations in humans and animal models characterize absorption, hepatic metabolism (phase I/II conjugation), plasma protein binding, and renal elimination, with analytical quantification by HPLC and LC–MS/MS. Drug–drug interaction potential has been evaluated with cytochrome P450 isoenzymes profiling common to pharmacology studies.

Toxicity and safety

Safety assessments of rhein encompass acute and chronic toxicity, genotoxicity, and organ-specific adverse effects. In animal models, high doses can produce gastrointestinal irritation, hepatotoxicity, and nephrotoxic changes; some studies report tubular alterations in rodent kidneys at sustained exposure levels. Genotoxicity assays yield variable results depending on assay system and metabolite formation, prompting regulatory scrutiny in herbal product evaluation frameworks overseen by agencies such as European Medicines Agency and national authorities. Safety recommendations for traditional preparations emphasize dose limitation, contraindications in pregnancy, and monitoring when coadministered with agents affecting renal or hepatic function.

Industrial and analytical applications

Beyond pharmacology, rhein and related anthraquinones have roles in dye and pigment industries, analytical standards for chromatographic methods, and as chemical scaffolds in medicinal chemistry programs. Analytical workflows use rhein as a marker compound for quality control of botanical raw materials (for example, in pharmacopeia monographs) employing thin-layer chromatography, HPLC, and spectroscopic fingerprinting. Chemical modification of the carboxylate or hydroxyl groups yields derivatives with altered solubility, stability, or bioactivity, informing lead optimization efforts in drug discovery and formulation science.

Category:Anthraquinones Category:Natural products